High serum IGFBP7 levels (≥35.80 ng/ml) were associated with a significantly increased risk of MetS with the adjusted OR of 2.758 (95% CI = 2.308 – 3.297) (Table 3). The gene discussed is IGFBP7; the disease is metabolic syndrome.